Skip to main content
OpenTrials
Completed

NCT Number: NCT03196050

Telemonitoring of Geriatric Cancer Patients Using Handheld Devices

Cancer is becoming a chronic disease, with the requirement of a lifelong intake of cancer-controlling drugs. While young(er) patients may cope with this, geriatric cancer patients may require a more customized and tailored follow up.

Most elderly patients have multiple other diseases ("comorbidities") and, due to many other factors, may per se not tolerate or simply not follow anticancer therapies. This may not only impair quality of life (QoL), but on the long rung also the therapeutic outcome (survival).

Handheld devices provide a new reporting/communication tool for patients and health care providers. TeleGraPH will assess if these devices are a suitable communication modality in a cohort of geriatric cancer patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Radiotherapy University Hospital Mannheim

Mannheim, 68167, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 60 years
  • Karnofsky Performance Status ≥ 70
  • histologically confirmed malignant tumor (cancer)

Exclusion criteria

  • concurrent severe and/or uncontrolled concomitant medical conditions
  • Patients unwilling or unable to comply with using a handheld device

Treatment and study plan

Handheld Device (Smart Phone)

Device

Handheld device will be used for 3 tasks:

1x per day: status update ("how are you today"?)

1x per week: 10 questions on general health status

1x per month: EORTC QLQ-C30 questionnaire

Primary outcomes

  1. Device Adherence/Compliance

    Time frame: 1 Year

    Frequency of using the handheld device and of daily/weekly/monthly reportings

Secondary outcomes

  1. Quality of Life

    Time frame: 1 Year

    Assessed using the EORTC QLQ-C30 questionnaire

  2. Reliability of reports

    Time frame: 1 Year

    Patient-reported status will be compared to physician-rated status

Sponsors and collaborators

Lead sponsor

Universitätsmedizin Mannheim

Other

Collaborators

  • Hector-Stiftung
  • Vitaphone GmbH, Mannheim
  • humediQ global GmbH, Grünwald

Registry information

Official study title

Telemonitoring of Geriatric Cancer Patients Using Handheld Devices (TeleGraPH)

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Jun 22, 2017
Registry last updated
Jan 23, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.